Login / Signup

Update Alert 9: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Katherine MackeyDevan KansagaraKathryn Vela
Published in: Annals of internal medicine (2022)
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • human health
  • respiratory syndrome coronavirus
  • clinical decision support
  • risk assessment
  • binding protein
  • sars cov
  • coronavirus disease
  • climate change